511509 Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>VB</div>
511509 -- India Stock  

INR 27.10  0.60  2.26%

Assuming the 30 trading days horizon, and your above-average risk tolerance our recommendation regarding VIVO BIO TECH is 'Not Rated'. Macroaxis provides VIVO BIO buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding VIVO BIO positions. The advice algorithm takes into account all of VIVO BIO TECH available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from VIVO BIO buy-and-hold perspective. Please continue to Trending Equities.

Search Advice

 
Refresh

Time Horizon

Risk Tolerance

Execute Advice
Sell VIVO BIOBuy VIVO BIO
Not Rated
For the selected time horizon VIVO BIO TECH has a risk adjusted performance of 0.0067, jensen alpha of (0.037225), total risk alpha of (0.94) and treynor ratio of (0.16)
Our buy or sell recommendation module can be used to complement current analysts and expert consensus on VIVO BIO TECH. Our recommendation engine harnesses analyzes the company potential to grow using all fundamental data market data available at this particular time. To make sure VIVO BIO TECH is not overpriced, please validate all VIVO BIO fundamentals, including its price to book, revenue, ebitda, as well as the relationship between the price to sales and gross profit .

VIVO BIO Trading Alerts and Improvement Suggestions

VIVO BIO TECH is not yet fully synchronised with the market data
VIVO BIO TECH generates negative expected return over the last 30 days
VIVO BIO TECH has high historical volatility and very poor performance
VIVO BIO TECH has high likelihood to experience some financial distress in the next 2 years
The company has accumulated about 28.22 M in cash with (56.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.02.

VIVO BIO Returns Distribution Density

The chart of the probability distribution of VIVO BIO stock daily returns describes the distribution of returns around its average expected value. We use VIVO BIO TECH' stock's Value At Risk and its Upside Potential as a relative measure of the distribution. The distribution of VIVO BIO returns is essential to provide solid investment advice for VIVO BIO stock.
Mean Return-0.0075Value At Risk-14.17
Potential Upside24.20Standard Deviation9.49
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of VIVO BIO historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

About VIVO BIO Buy or Sell Advice

When is the right time to buy or sell VIVO BIO TECH? Buying stocks such as VIVO BIO isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily bases. Although VIVO BIO investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply. Please read more on our stock advisor page.

Did You Try This Idea?

Run Education Thematic Idea Now

Education
Education Theme
Companies involved in apprenticeship, education, tutoring, schooling, online universities, and other learning services. Education theme has 21 constituents.
View All  Next Launch Education
Please continue to Trending Equities. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page